Eckert & Ziegler SE (MIL:1EUZ) Cash-to-Debt : 1.88 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Eckert & Ziegler SE Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Eckert & Ziegler SE's cash to debt ratio for the quarter that ended in Sep. 2024 was 1.88.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Eckert & Ziegler SE could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for Eckert & Ziegler SE's Cash-to-Debt or its related term are showing as below:

MIL:1EUZ' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.12 Med: 3.1 Max: 1290.14
Current: 1.88

During the past 13 years, Eckert & Ziegler SE's highest Cash to Debt Ratio was 1290.14. The lowest was 1.12. And the median was 3.10.

MIL:1EUZ's Cash-to-Debt is ranked better than
50.35% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: 1.815 vs MIL:1EUZ: 1.88

Eckert & Ziegler SE Cash-to-Debt Historical Data

The historical data trend for Eckert & Ziegler SE's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Eckert & Ziegler SE Cash-to-Debt Chart

Eckert & Ziegler SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

3.97

4.34

3.52

1.67

1.21

Eckert & Ziegler SE Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial															1.39	1.21	1.18	1.40	1.88

Competitive Comparison of Eckert & Ziegler SE's Cash-to-Debt

For the Medical Devices subindustry, Eckert & Ziegler SE's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eckert & Ziegler SE's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Eckert & Ziegler SE Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Eckert & Ziegler SE's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	67.998	/	(8.948	+	47.356)
	=	1.21

Eckert & Ziegler SE's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	97.63	/	(9.221	+	42.7)
	=	1.88

Eckert & Ziegler SE (MIL:1EUZ) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Eckert & Ziegler SE Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Eckert & Ziegler SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (MIL:1EUZ) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

EUZd:UK 0NZY:UK EUZ:Germany EUZ:Germany EUZ:Germany EUZ:Germany

Address

Robert-Rossle-Street 10, Berlin, BB, DEU, 13125

Website

https://www.ezag.com

Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Eckert & Ziegler SE Headlines

No Headlines